Gene Therapy and the Future of Hearing Care: A Conversation with Dr. Jonathon Whitton

Gene therapy is no longer a future possibility—it’s here. In this episode, Emily Venskytis and Maggie Kettler sit down with Dr. Jonathon Whitton, Vice President and Global Program Head of Genetic Medicines at Regeneron, to discuss the first-ever gene therapy for genetic hearing loss. From molecular diagnosis and genetic testing to changing standards of care and emerging treatment pathways, Dr. Whitton shares how precision medicine is reshaping the future of hearing healthcare and why audiologists will play a critical role in this new era.